title: Clinical and pathologic prognostic factors that are influential in the survival and prognosis of lung adenocarcinomas and invasive predominant subtypes.
abstract: Therapeutic approaches to lung adenocarcinomas differ because of their heterogeneous morphologies, prognoses, and clinical features. For this reason, new histopathologic classifications for lung adenocarcinomas were done by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society to form subtypes with homogeneous prognoses. There are limited clinical data in the literature on the prognosis of the subgroups formed according to the new classification. A total of 86 patients with adenocarcinoma who had undergone pathologic stages I and II curative resection and mediastinal lymph node dissection were retrospectively analyzed according to the seventh TNM staging system revised by the Union for International Cancer Control/American Joint Committee on Cancer. Histologic subtyping was reassessed according to the dominant histopathologic morphology. When survival rates of lung adenocarcinomas were compared according to their localizations, it was observed that adenocarcinomas localized to the right hemithorax had a longer survival than the ones with left hemithorax localization (P = 0.026). When necrosis was taken into account, it was seen that necrosis rate was higher in solid predominant type compared with other types, whereas it was lower in acinary type (P = 0.046). When peritumoral lymphovascular invasion data were assessed, it was observed that disease-free survival was influenced in a negative fashion (P = 0.018). New histopathologic classification of adenocarcinomas has been a step forward to attaining homogeneous groups, but when the biologic heterogeneity of the adenocarcinomas is taken into account, the authors believe that considering the peritumoral lymphatic vascular invasion, left hemithorax localization, and tumoral necrosis entities in the upcoming TNM classification will contribute to evaluating the prognosis.
authors: 1 Department of Thoracic Surgery, School of Medicine, Mugla Sıtkı Koçman University, Mugla, Turkey.
authors: Arife
authors: A
authors: Zeybek
authors: Serap
authors: S
authors: Toru
authors: Irem Hicran
authors: IH
authors: Ozbudak
authors: Alpay
authors: A
authors: Sarper
authors: Necdet
authors: N
authors: Oz
authors: Hakan
authors: H
authors: Bozcuk
authors: Gülay
authors: G
authors: Ozbilim
authors: Abid
authors: A
authors: Demircan
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D000368:Aged; D001706:Biopsy; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods*; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate
references: J Thorac Oncol. 2007 Aug;2(8):706-14
references: 17762336
references: J Thorac Oncol. 2011 Sep;6(9):1496-504
references: 21642859
references: Ann Thorac Surg. 2011 Apr;91(4):1051-7
references: 21440121
references: Mod Pathol. 2011 May;24(5):653-64
references: 21252858
references: Lung Cancer. 2010 Mar;67(3):282-9
references: 19481833
references: Mod Pathol. 2008 Aug;21(8):992-1001
references: 18516041
references: Cancer. 2010 Feb 1;116(3):659-69
references: 20014400
references: J Thorac Oncol. 2011 Feb;6(2):244-85
references: 21252716
references: Clin Chest Med. 1982 May;3(2):257-89
references: 6284435
references: Am J Surg Pathol. 2003 Jan;27(1):101-9
references: 12502932
references: Ann Thorac Surg. 2006 Jun;81(6):1988-95
references: 16731118
references: Ann Surg Oncol. 2012 Oct;19(11):3598-605
references: 22644511
references: Am J Surg Pathol. 2009 Mar;33(3):462-9
references: 19092635
references: Am J Surg Pathol. 2010 Aug;34(8):1155-62
references: 20551825
references: Histopathology. 2005 Jun;46(6):677-84
references: 15910599
references: Lung Cancer. 2012 Aug;77(2):394-400
references: 22542172
references: Mod Pathol. 2007 May;20(5):514-21
references: 17334347
references: Mod Pathol. 2007 Jun;20(6):638-47
references: 17431413
references: Cancer. 1995 Jun 15;75(12):2844-52
references: 7773933